Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Does Cancer-Related Weight Loss Reduce Immunotherapy Efficacy?

Does Cancer-Related Weight Loss Reduce Immunotherapy Efficacy?

Successful immunotherapies have become important in malignant melanoma, lung, kidney, bladder, head and neck cancers and Hodgkin lymphoma. Designed to activate immunity against cancer, immunotherapiesdo not work equally in every patient. Researchers identified cancer-related weight loss as potentially reducing efficacy.

Weight loss and poor appetite in cancer are known as cancer cachexia . It appears earlier in certain cancers, such as pancreatic cancer. Recent research has examined how it affects treatment response.

In November 2016, the respected journal Cell Metabolismpublished research showing that metabolic changes may reduce immunotherapy efficacy . Mice with early cancer but no cachexia were studied, comparing efficacy before and after cachexia.

According to the Research Results:

  • Cancer cells affected liver function through interleukin 6 (IL-6). The liver stores nutrients needed for energy. IL-6 shuts down mechanisms producing energy during low intake. Inadequate energy production triggers a hormonal response preventing anticancer immunity.

What Does This Study Mean Clinically?

  • Similar human experiments may enable treatments correcting metabolic changes,
  • Tests predicting which patients benefit from immunotherapy may be developed,
  • The study guides development of effective immunotherapies also targeting cancer cachexia.

Sources

Flint et al.,
Tumour induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumour Immunity.
Cell Metabolism.2016, 24(5),672-684

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Does Cancer-Related Weight Loss Reduce Immunotherapy Efficacy?

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy